Poland· PL-100120830
Venescin forte
A hippocastani semen product containing hippocastani seminis extractum siccum + rutosidum, registered in Poland by Wrocławskie Zakłady Zielarskie "Herbapol" S.A.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hippocastani semen is registered in 7 of 19 countries.
Countries holding a registration under ATC C05CX03 (hippocastani semen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Hippocastani semen · ATC C05CX03
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Hippocastani seminis extractum siccum + Rutosidum
- Manufacturer
- Wrocławskie Zakłady Zielarskie "Herbapol" S.A.
- Country
- Poland (PL)
- ATC code
- C05CX03
- ATC class
- Hippocastani semen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991036515
- gtin05909991036522
- gtin05909990847556
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C05CX03
Hippocastani semen, as other registers publish it.
- NetherlandsA. Vogel Aesculaforce tablettenA.Vogel B.V.
- DenmarkAesculaforce forteA. Vogel Danmark A/S
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculamed forte Venen
- SwitzerlandAesculamed forte Venen
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/897394fc-24c0-4ee6-b0ad-8a76f0c7376a GET /v1/drugs/897394fc-24c0-4ee6-b0ad-8a76f0c7376a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki drażowane",
"source": "urpl",
"strength": "100 mg + 60 mg",
"packaging": "05909991036515 ¦ OTC ¦ Skasowane ¦ 22631\n30 tabl. (3 x 10)\n05909991036522 ¦ OTC ¦ 22634\n30 tabl.\n05909990847556 ¦ OTC ¦ Skasowane ¦ 64714\n60 tabl.",
"substance": "Hippocastani seminis extractum (5,5-8:1) (ekstrahent - etanol 70%) 100 mg + Rutosidum trihydricum 60 mg",
"common_name": "Hippocastani seminis extractum siccum + Rutosidum",
"pl_product_id": "100120830",
"pozwolenie_nr": "10365",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about hippocastani semen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.